 Home > Biochemistry News > Biotechnology News > The first domestic cervical cancer vaccine obtained pre-certification by the World Health Organization

The first domestic cervical cancer vaccine obtained pre-certification by the World Health Organization

 Last Update: 2021-11-01
 Source: Internet
 Author: User

Tags

global

human serum

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 26, the State Food and Drug Administration announced that recently, the World Health Organization stated that the domestic bivalent human papillomavirus vaccine (Xinkening®, Cecolin®) produced by Xiamen Wantai Canghai Biotechnology Co.

Xinkening Bivalent Human Papillomavirus Vaccine (Type 16 and Type 18) is a vaccine for injection.

The Xinkening bivalent human papillomavirus vaccine has been pre-certified by the World Health Organization, becoming the sixth pre-certified domestic vaccine in China, marking that China's vaccine product supervision, development and production system and product quality have achieved international standards.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.